New Paradigms is guided by key individuals from biotech, pharma and the investment community to advance R&D through alternative sources of funding, non-traditional partnering strategies and innovative approaches to drug approval for the successful commercialization of new therapies. The conference is backed by an exceptionally distinguished speaking faculty with diverse experience and expertise in:

• Alternative financial sources, non-profit and government funding

• Meeting expectations in partnerships from investors and biotechs

• Who is getting funded and who is not and why

• Essential ingredients to regulatory success

• Preparing and adapting for market disruptions

• CEO insights on what it takes to be successful and lessons learned

• What biopharma investors are looking for in biotech partners

• Opportunities in China

• How to conduct commercial assessment on a drug with a tight budget?

• New paradigms to getting your drug approved

• Executing innovative clinical trials that save time, money and improve outcomes

• Plasma and imaging biomarkers that drive value and improve success rates

• Best practices in reimbursement

As a business development conference, rather than a traditional partnering event, this program is a wonderful complement to the JP Morgan conference. It allows you to learn in a relaxed environment from professionals who have succeeded in developing products using an alternative source of funding with innovative development planning. Biotech and investment networking and on-one-one meeting time is built into the conference with scheduled breaks, a luncheon and reception. A Partnering Service Desk will be available on site at the conference to assist you with scheduling meetings with fellow attendees.